Skip to main content
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · SNOA ISIN · US83558L2043 US Manufacturing
Open in API
Filings indexed 951 across all filing types
Latest filing 2019-01-08 Delisting Announcement
Country US United States of America
Listing US SNOA

About Sonoma Pharmaceuticals, Inc.

https://sonomapharma.com/

Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and commercializes products based on its patented Microcyn® Technology, a stabilized hypochlorous acid (HOCl) platform. With over 20 years of experience, the company produces a range of prescription and over-the-counter solutions for advanced wound care, dermatology, animal health, and eye care. Its products are designed to manage various conditions by promoting healing and reducing the risk of infection. The portfolio serves healthcare professionals in settings like hospitals and nursing homes, as well as consumers for at-home use.

Recent filings

Filing Released Lang Actions
CURRENT REPORT
Delisting Announcement Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC, dated January 4, 2019, by Sonoma Pharmaceuticals, Inc. The content focuses on a notification from Nasdaq regarding the company's failure to maintain the minimum bid price required for continued listing, and the potential consequences including delisting if compliance is not regained. The document is a regulatory announcement about the company's listing status and compliance with exchange rules, not a full financial report or earnings release. It is not a report publication announcement since it contains substantive information about the delisting notice. Therefore, the appropriate classification is a Delisting Announcement (DLST).
2019-01-08 English
Director's Dealing 2018
Director's Dealing
2018-12-21 English
FORM S-8
Capital/Financing Update Classification · 100% confidence The document is a Form S-8 registration statement filed with the SEC by Sonoma Pharmaceuticals, Inc. It registers securities under the Securities Act of 1933 related to stock incentive plans and inducement stock option awards. The text includes details about the registration fee, incorporation by reference of other filings (10-K, 10-Q, 8-K, proxy statements), and legal undertakings. Form S-8 is a registration statement for securities issued to employees and is not a financial report, earnings release, or management discussion. It is a capital/financing related filing as it pertains to registration of securities for issuance under stock plans. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is the registration statement itself, not just an announcement or certification.
2018-12-19 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is used for current reports on significant events. The content details the appointment of a new CEO and interim CFO, the resignation of previous executives, and related employment and separation agreements. This corresponds to announcements about changes in the company's board of directors and senior management. There are no financial statements or earnings data presented, so it is not an annual or quarterly report. The document fits the category of Board/Management Information (MANG). The document length is 8818 characters, which is sufficient for a detailed announcement rather than a brief notice or certification.
2018-12-14 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text indicates it is a response letter to shareholder communications requesting a strategic review, furnished as an exhibit. There are no financial statements or detailed financial data presented, nor is this an annual or quarterly report. The document is not a proxy, earnings release, or management discussion. It is a regulatory filing reporting a corporate event or communication. Given the nature and content, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2018-11-28 English
FORM 8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement related to a placement agency agreement for a public offering of securities, including common stock, preferred stock, and warrants. It details the terms of the offering, fees, lock-up agreements, and related agreements. There are no financial statements or comprehensive financial data presented, nor is this an earnings release or annual/interim report. The document is clearly an announcement of a capital raising event and related agreements, which fits the category of Capital/Financing Update (CAP). The length and detail confirm it is not a brief announcement or a simple notice but a full current report on financing activity.
2018-11-21 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.